Skip to main content

Eventide Asset Management, LLC

SEC CIK
0001442891
Latest filing
Aug 14, 2026

CSTL holding history

Castle Biosciences Inc in every 13F filed by Eventide Asset Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CSTL overviewAll 13F holders of CSTLFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
2
Since Q4 2025
Holdings of CSTL by Eventide Asset Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−386,425−100.0%Sold outHolders
Q1 2026386,425$9.49M0.2%+81,425+26.7%AddedHolders
Q4 2025305,000$11.9M0.2%+305,000NewHolders